Genovis AB (publ.) (STO:GENO)
Sweden · Delayed Price · Currency is SEK 21.35
-0.30 (-1.39%)
Nov 2, 2026, 5:24 PM CET
Genovis AB (publ.) Market Cap
Genovis AB (publ.) has a market cap or net worth of 1.44 billion as of November 2, 2026. It is the 22,428th most valuable company in the world and the 283rd biggest in Sweden. Its market cap has decreased by 5.42% in one year.
Market Cap
1.44B
Enterprise Value
1.36B
Revenue
135.89M
Global Rank
Country Rank
#283 Sweden
PE Ratio
68.96
ChartMarket Cap Chart
Since April 18, 2008, Genovis AB (publ.)'s market cap has increased from 7.51M to 1.44B, an increase of 19,068.57%. That is a compound annual growth rate of 32.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 1.44B | 2.59% |
| Dec 30, 2025 | 1.40B | -13.18% |
| Dec 30, 2024 | 1.62B | -52.50% |
| Dec 29, 2023 | 3.40B | 13.17% |
| Dec 30, 2022 | 3.01B | -37.05% |
| Dec 30, 2021 | 4.78B | 131.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 4.00B |
| Vicore Pharma Holding AB | 2.73B |
| Saniona AB | 1.54B |
| Flerie AB | 1.21B |
| Medivir AB | 967.26M |
| SynAct Pharma AB | 908.29M |
| Infant Bacterial Therapeutics AB | 885.07M |
| AlzeCure Pharma AB | 882.54M |